-
-
-
-
-
-
-
Sanofi delivers strong 2019 business EPS growth of 6.8% at CER
-
-
-
-
-
-
-
Lexicon Pharma (LXRX), Sanofi (SNY) Announce FDA to Review Zynquista as Potential Treatment for Type 1 Diabetes
-
-
-
-
-
-
-
Sanofi Delivers Robust Q1 2017 Financial Results
-
-
-
-
-
-
-
Sanofi Announces Strong Q3 2016 Results
-
-
-
-
-
-
-
Bradley Campbell, President and COO of Amicus Therapeutics, elected to Progenics Board of Directors
-
-
-
-
-
-
12,341 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All